Literature DB >> 8760084

Kinetic analysis of receptor-mediated endocytosis of G-CSF derivative, nartograstim, in rat bone marrow cells.

T Kuwabara1, S Kobayashi, Y Sugiyama.   

Abstract

To elucidate the mechanism of the receptor-mediated clearance of granulocyte colony-stimulating factor (G-CSF), we performed kinetic analyses of the receptor-mediated endocytosis (RME) processes using a human G-CSF derivative, nartograstim (NTG), and isolated rat bone marrow cells. The first-order rate constants involved in RME processes were obtained by computerized model fitting of the time courses of the ligand-receptor complex on both the cell surface and in the cell interior and the degradation products in the medium in the pulse-chase experiment. They were also calculated based on a kinetic model involving the ligand concentration dependence of the initial binding rate, the steady-state degradation rate, and the steady-state amounts of ligand on both the cell surface and in the interior. The rate constants for the RME processes after receptor binding determined in the different experiments were similar, that is, the half-times for the dissociation, internalization, and degradation of the ligand-receptor complex were 770, 10-30, and 20 min, respectively. However, the association constant obtained by measuring the initial binding was fivefold greater than that calculated under steady-state conditions. These kinetic analyses support the hypothesis that the internalization of the receptor may be accelerated by ligand binding, causing downregulation of the receptor on the cell surface. These overall kinetic analyses based on steady-state and non-steady-state data of the RME processes clarify the dynamics of the interaction between NTG and its receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760084     DOI: 10.1152/ajpendo.1996.271.1.E73

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  A novel hepatic-targeting system for therapeutic cytokines that delivers to the hepatic asialoglycoprotein receptor, but avoids receptor-mediated endocytosis.

Authors:  Haruya Sato; Yukio Kato; Eiko Hayasi; Tomoyuki Tabata; Manabu Suzuki; Yoshiyuki Takahara; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.

Authors:  Pete Heinzelman; Sharon J Carlson; George N Cox
Journal:  Protein Eng Des Sel       Date:  2015-04-07       Impact factor: 1.650

Review 3.  Pharmacokinetics and pharmacodynamics of pegfilgrastim.

Authors:  Bing-Bing Yang; Anna Kido
Journal:  Clin Pharmacokinet       Date:  2011-05       Impact factor: 6.447

4.  Characterization of endogenous G-CSF and the inverse correlation to chemotherapy-induced neutropenia in patients with breast cancer using population modeling.

Authors:  Angelica L Quartino; Mats O Karlsson; Henrik Lindman; Lena E Friberg
Journal:  Pharm Res       Date:  2014-06-12       Impact factor: 4.200

5.  Development of Site-Specific PEGylated Granulocyte Colony Stimulating Factor With Prolonged Biological Activity.

Authors:  Monika Kumari; Girish Sahni; Sonal Datta
Journal:  Front Bioeng Biotechnol       Date:  2020-11-19

6.  Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.

Authors:  Sibylle Schirm; Christoph Engel; Sibylle Loibl; Markus Loeffler; Markus Scholz
Journal:  J Cancer Res Clin Oncol       Date:  2017-11-04       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.